Angiotensin Ii like activity in the plasma of normal subjects and patients with renal hypertension
Vohra, S.K.; Chugh, K.S.; Chaudhury, R.R.; Chhuttani, P.N.
Journal of the Association of Physicians of India 20(5): 347-352
1972
ISSN/ISBN: 0004-5772 PMID: 4347826 Document Number: 45555
Document emailed within 1 workday
Related Documents
Zeravica, R.; Stosić, Z.; Ilincić, B.; Crnobrnja, V.; Jakovljević, A.; Mijović, R. 2014: The effect of angiotensin converting enzyme inhibition on effective renal plasma flow in patients with diffuse renal parenchymal diseases and hypertension Medicinski Pregled 67(3-4): 78-82Collart, F.; Staroukine, M.; Verniory, A. 1985: Relationships between blood pressure, heart rate and plasma epinephrine, norepinephrine, angiotensin II concentrations, plasma renin activity during chronic guanfacine therapy in patients with essential arterial hypertension Acta Cardiologica 40(3): 269-276
Lambert, P.W.; DeOreo, P.B.; Hollis, B.W.; Fu, I.Y.; Ginsberg, D.J.; Roos, B.A. 1981: Concurrent measurement of plasma levels of vitamin D3 and five of its metabolites in normal humans, chronic renal failure patients, and anephric subjects Journal of Laboratory and Clinical Medicine 98(4): 536-548
Mizutani, S.; Sakura, H.; Akiyama, H.; Kobayashi, H. 1983: Changes in plasma renin activity (PRA), angiotensin I and placental leucine aminopeptidase (P-LAP) activity during normal pregnancy Nihon Sanka Fujinka Gakkai Zasshi 35(4): 545-549
Gulati, O.P.; Nanivadekar, S.A.; Chakravarti, R.N.; Sen, P.K. 1974: Plasma angiotensin-like activity in hypertension Journal of the Association of Physicians of India 22(2): 139-142
Lijnen, P.; Staessen, J.; Amery, A. 1982: Assay of plasma angiotensin-converting enzyme activity in captopril-treated subjects Methods and Findings in Experimental and Clinical Pharmacology 4(6): 413-415
Egberg, N.; Gallimore, M.J. 1983: Studies on Hageman factor, plasma prekallikrein, kallikrein "like" activity and kallikrein inhibition in plasma samples from normal subjects and clinical material Advances in Experimental Medicine and Biology 156: 1109-1117
Wiecek, A.; Heidland, A.; Gilge, U.; Kokot, F.; Kuczera, M.; Kiersztejn, M. 1993: Enhanced activity of sympathetic renal nerves in hypertensive patients with unilateral renal ischemia--its relationship to plasma renin activity in renal venous blood Clinical Nephrology 40(6): 326-331
Gulati, O.P.; Chakravarti, R.N.; Sharma, P.L. 1974: Serial study of plasma angiotensin, electrolytes and juxta-glomerular index in experimental renal hypertension of monkeys Indian Journal of Medical Research 62(1): 86-92
Forette, F.; Ménard, J.; Forette, B.; Henry, J.F.; Berthaux, P. 1978: Plasma renin activity in normal and hypertensive aged subjects. Preliminary results Annales de Medecine Interne 129(6-7): 399-403
Zonis, B.Ia.; Volkova, N.I.; Sokolov, O.Iu. 2000: Ednit effects on activity of renin-angiotensin-aldosterone system and renal function in hypertensive subjects with diabetes mellitus Terapevticheskii Arkhiv 72(2): 53-55
Michel, B.; Grima, M.; Coquard, C.; Welsch, C.; Barthelmebs, M.; Imbs, J.L. 1993: Plasma renin activity and angiotensin converting enzyme of renal brush borders Archives des Maladies du Coeur et des Vaisseaux 86(8): 1245-1248
De Ferrari, G.; Gaiter, A.; Ginevri, F.; Tizianello, A. 1979: Effects of pindolol on arterial pressure and plasma renin activity in essential hypertension and in hypertension during chronic renal insufficiency La Clinica Terapeutica 90(5): 461-468
Wocial, B.; Januszewicz, W.; Bar-Andziak, E.; Grzesiuk, W.; Kuczyńska, K.; Berent, H.; Ignatowska-Switalska, H.; Kapiński, M.; Młyński, J. 1990: Platelet activity, prostacycline metabolite, plasma lipids and sympathoadrenal activity in patients with borderline hypertension and a positive family history of hypertension Cor et Vasa 32(4): 265-273
Miyazaki, N.; Shionoiri, H.; Uneda, S.; Yasuda, G.; Gotoh, E.; Fujishima, S.; Kaneko, Y.; Kawahara, Y.; Yamazaki, Y. 1982: Blood concentration and urinary excretion of captopril (SQ 14,255), angiotensin converting enzyme activity and R-A-A system after administration of captopril--in patients with chronic renal failure compared with essential hypertension Nihon Jinzo Gakkai Shi 24(4): 421-428
Ocón, J.; Piña, C.; Castellet, R.; Vila, R.; del Río, G.; Arnau, C. 1985: Clinical evaluation of penbutolol (Hoe 893d) (beta adrenergic blocker), alone and in combination with hydrochlorothiazide, in the treatment of arterial hypertension. II. Effect on plasma electrolytes, renal function, plasma renin and aldosterone activity and risk factors, including plasma lipids Medicina Clinica 85(2): 53-57
Rasmussen, S.; Ibsen, H.; Giese, J. 1984: Contrasting effects of the renin-angiotensin system on renal function disclosed during converting enzyme inhibition in patients with renal hypertension Scandinavian Journal of Urology and Nephrology. Supplementum 79: 49-52
Tacquet, A.; Devulder, B.; Cuvelier, D.; Legros, J. 1974: Pharmacokinetic aspects of thiamphenicol in subjects with normal renal function and in patients with chronic renal insufficiency, with or without haemodialysis Postgraduate Medical Journal 50(Suppl 5): 36-38
Vetter, H.; Zumkley, H.; Glänzer, K.; Witassek, F.; Wollnik, S.; Vetter, W. 1980: Renin-angiotensin-aldosterone system in essential hypertension. Inappropriately high plasma aldosterone in young patients with severe hypertension and in older hypertensives Schweizerische Medizinische Wochenschrift 110(50): 1938-1941
Recordati, G.; Zorzoli, F.; Zanchetti, A. 2000: Effects of a reversible 'nephrectomy' on renal sympathetic activity and blood pressure in the rat: evidence for an acute angiotensin-mediated hypertension Journal of Hypertension 18(9): 1277-1287